You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康哲藥業(00867.HK):康聯達與君實生物(01877.HK)訂立股東協議
康哲藥業(00867.HK)宣布,於2023年3月27日,通過公司東南亞業務康聯達生技(Rxilient Biotech Pte. Ltd.)及Excellmab Pte. Ltd.與君實生物(01877.HK)訂立股東協議,君實生物將以非貨幣方式出資認購Excellmab新發行的股份以獲得其40%的股權。 受限於股東協議項下約定的先決條件達成,君實生物將實質履行出資義務,並計劃按照訂立股東協議時各方已商定的文本與Excellmab訂立獨佔許可協議,Excellmab將獲得在泰國、文萊、柬埔寨、印度尼西亞、老撾、馬來西亞、緬甸、菲律賓及越南開發和商業化靜(月永)注射用特瑞普利單抗的獨佔許可及其他相關權利。(ca/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account